Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Post

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|April 5, 2000
Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptorB S Gaul, M L Harrison, R L Geahlen, et al.
Critical Reviews in Oncology/Hematology|June 5, 2020
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancerCathalijne C B Post, Anneke M Westermann, Tjalling Bosse, et al.
Journal of Molecular Biology|August 5, 1986
Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuationsC B Post, B R Brooks, M Karplus, et al.
Biophysical Journal|February 4, 1998
Energetics of quasiequivalence: computational analysis of protein-protein interactions in icosahedral virusesV S Reddy, H A Giesing, R T Morton, et al.
Structure (London, England : 1993)|June 30, 2000
Structure and self-association of the Rous sarcoma virus capsid proteinR L Kingston, T Fitzon-Ostendorp, E Z Eisenmesser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2018
Patterns of re-irradiation for recurrent gliomas and validation of a prognostic scoreCathalijne C B Post, Miranda C A Kramer, Ernst J Smid, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|April 5, 2000
Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptorB S Gaul, M L Harrison, R L Geahlen, et al.
Critical Reviews in Oncology/Hematology|June 5, 2020
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancerCathalijne C B Post, Anneke M Westermann, Tjalling Bosse, et al.
Journal of Molecular Biology|August 5, 1986
Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuationsC B Post, B R Brooks, M Karplus, et al.
Biophysical Journal|February 4, 1998
Energetics of quasiequivalence: computational analysis of protein-protein interactions in icosahedral virusesV S Reddy, H A Giesing, R T Morton, et al.
Structure (London, England : 1993)|June 30, 2000
Structure and self-association of the Rous sarcoma virus capsid proteinR L Kingston, T Fitzon-Ostendorp, E Z Eisenmesser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2018
Patterns of re-irradiation for recurrent gliomas and validation of a prognostic scoreCathalijne C B Post, Miranda C A Kramer, Ernst J Smid, et al.
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Pageof 5